(Q41845460)

13 October 2017

Cancer immunotherapy--the endgame begins (English)

1 reference

13 October 2017

1 reference

Louis M Weiner

1

1 reference

PMC publication ID

2728623

13 October 2017

language of work or name

English

0 references

publication date

1 June 2008

1 reference

13 October 2017

2

1 reference

The New England Journal of Medicine

inferred from page(s)

published in

1 reference

13 October 2017

358

1 reference

13 October 2017

25

1 reference

13 October 2017

2664-2665

1 reference

Immunosuppressive strategies that are mediated by tumor cells

13 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2728623

Cancer regression in patients after transfer of genetically engineered lymphocytes

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2728623

Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2728623

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2728623

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

6 June 2018

1 reference

12 December 2020

Treatment of B-Cell Lymphoma with Monoclonal Anti-Idiotype Antibody

1 reference

12 December 2020

Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell dose

1 reference

12 December 2020

Immunotherapy of cancer: the end of the beginning?

1 reference

12 December 2020

Augmented HER-2 specific immunity during treatment with trastuzumab and chemotherapy

1 reference

12 December 2020

Identifiers

DOI

10.1056/NEJMP0803663

1 reference

13 October 2017

1 reference

PMC publication ID

2728623

13 October 2017

PubMed publication ID

18565858

1 reference

PMC publication ID

2728623